Finally, in vivo experimental therapeutic models showed that anakinra suppressed tumor growth, lymph node metastasis, angiogenesis, lymphangiogenesis, and M2-type macrophage infiltration, accompanied by significantly reduced expression of VEGF-A, VEGF-C, and VEGF-D (Figures 4 and 6). Here, VEGFC is linked to neoplasm.